MedPath

Effect of PEP'C-R on Endurance Parameters and Maximal Cardio-respiratory Function Among Sedentary Older Seniors Over 70

Not Applicable
Terminated
Conditions
Sedentary Lifestyle in Patients Over 70
Interventions
Other: PEP'C-R
Other: Control group usual activities
Registration Number
NCT02263573
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

The primary purpose of the protocol is to determine the effects of a new program of PEP'C "PEP'C with constant load and intermittent recovery" (PEP'C-R) on endurance parameters of older seniors.

The study hypothesis: the investigators propose that PEP'C-R training offers a significant improvement in endurance parameters for older seniors.

The secondary objectives are to determine the effects of PEP'C-R on maximal cardio-respiratory function, FMD (Flow-mediated dilation), PWV (pulse wave velocity), systolic and diastolic heart function, body composition (measured by impedance), biological, functional and cognitive functioning and quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Low physical activity determined using the questionnaire IPAQ in METs (<3).
  • Informed about the results of examinations performed at screening visit.
  • Subject able to understand the purpose, procedures and risks of the study and give written informed consent.
Exclusion Criteria
  • Contraindications to perform the cardiac stress test and PEP'C-R (Musculoskeletal limitations, Unstabilized heart Failure with chest pain on exertion under maximal medical therapy, ventricular and supraventricular disorders, Acute coronary syndrome within <1 month, Unstabilized respiratory failure or oxygen-dependent)
  • Abnormality shown at the cardiac stress test : clinical abnormality (chest pain), electric abnormality (found on ECG), abnormal blood pressure, abnormality of the ventilatory system (bronchospasm, hypoxemia,...)
  • Cognitive impairment which exclude PEP'C-R training.
  • Current Cancer chemotherapy.
  • Visual Impairment which exclude PEP'C-R training.
  • Presence of fibromyalgia.
  • Subject treated with beta-blockers and other negative chronotropic molecules.
  • Acute infection at the time of inclusion.
  • Dependent patient.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PEP'C-RPEP'C-RSubjects will benefit from one preliminary session and 18 sessions of PEP'C-R, (2 sessions per week for 9.5 weeks).
Control groupControl group usual activitiesSubjects do not participate in the program PEP'C-R and continue their usual activities at home for 9.5 weeks.
Primary Outcome Measures
NameTimeMethod
Change in intensity in W of the first ventilatory threshold (VT1)From baseline to 9.5 weeks

Determine the intensity in W of the first ventilatory threshold (VT1) for the experimental group and for the control group.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpitaux Universitaires de Strasbourg

🇫🇷

Strasbourg Cedex, France

© Copyright 2025. All Rights Reserved by MedPath